CLASS II Drug recall · Reported 24 Jul 2019 · FDA Enforcement Report

Milrinone Lactate Injection 200 mcg 2 mg)/mL* recalled by Pfizer

Pfizer is recalling Milrinone Lactate Injection 200 mcg 2 mg)/mL* in 5% Dextrose Injection, 20 mg, distributed in Puerto Rico. The recall was initiated on 9 Jul 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #s: 85-516-KL; 85-517-KL, Exp. 1JAN2020; 86-601-KL; 86-603-KL; 86-618-KL, Exp. 1FEB2020; 87-707-KL, Exp. 1MAR2020; 91-205-KL, Exp. 1JUL2020; 92-306-KL, Exp. 1AUG2020.
Quantity recalled280340 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1487-2019
FDA event ID
83267
Recalling firm
Pfizer, New York, NY
Classification
Class II
Status
Terminated
Recall initiated
9 Jul 2019
FDA classified
12 Jul 2019
Reported
24 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

9 Jul 2019Recall initiated by company
12 Jul 2019Classified by FDA+3 days
24 Jul 2019Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: Bags have the potential to leak.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection, 20 mg/100 mL, 100 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-23, Barcode (01)00304092776233.

Where it was distributed

United States, PR, and Guam

Puerto Rico

Questions about this recall

Is Milrinone Lactate Injection 200 mcg 2 mg)/mL* in 5% Dextrose Injection, 20 mg recalled?

Yes. Pfizer recalled Milrinone Lactate Injection 200 mcg 2 mg)/mL* in 5% Dextrose Injection, 20 mg on 9 Jul 2019. The recall is Class II and its status is Terminated. Recall number D-1487-2019.

Why was it recalled?

Lack of Assurance of Sterility: Bags have the potential to leak.

Which lots are affected?

Lot #s: 85-516-KL; 85-517-KL, Exp. 1JAN2020; 86-601-KL; 86-603-KL; 86-618-KL, Exp. 1FEB2020; 87-707-KL, Exp. 1MAR2020; 91-205-KL, Exp. 1JUL2020; 92-306-KL, Exp. 1AUG2020.

Where was it sold?

United States, PR, and Guam

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pfizer

All 126

Other Milrinone lactate recalls

All 4